Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
New Recruit self-service event staffing platform puts KC’s PopBookings in the big game
While the Kansas City Chiefs might have narrowly missed their shot at the 2019 Super Bowl, the city was well represented as a source for event staffing at the game, revealed Erika Klotz, noting the power of Recruit, a new product from KC-based PopBookings. A client used the self-service platform to book 288 shifts for…
KCultivator Q&A: Nia Richardson an architect of startup support ‘born, made and raised on Prospect’
Editor’s note: KCultivators is a lighthearted profile series to highlight people who are meaningfully enriching Kansas City’s entrepreneurial ecosystem. Experience the world, engage with community, and execute ideas to get ahead — not only in life, but in building a legacy that stands the test of time, said Nia Richardson. A product of Kansas City Public…
IoT panel to startups: Demystify emerging tech and take risks, but prepare to fail fast
Entrepreneurs often get lost in the hype of emerging technologies like the Internet of Things, failing to effectively integrate new tech into their startups, said Don Sharp. “Whether it’s the latest, greatest thing or not — it’s no different than any other tool,” said Sharp, CEO of St. Louis-based Coolfire Solutions and panelist at RUMBLE’s…
Top founder salutes Rick Vaughn: A mustached hero with a herculean task
Editor’s note: The opinions expressed in this commentary are the author’s alone. The dude is amazing; the dude is a legend. He rocks a mustache and his name is Rick Vaughn. If you don’t know him, it’s too late. He’s already gone. Well, not quite gone; this isn’t an obituary. Rick is just retiring from…